Trizivir Tablet is a combination medication designed for the treatment of HIV-1 infection, containing three active ingredients: Abacavir sulfate (300 mg), Lamivudine (150 mg), and Zidovudine (300 mg). This powerful antiretroviral therapy works by inhibiting the replication of the HIV virus, thereby helping to manage the infection and improve the immune system’s function. Each component plays a crucial role in the overall effectiveness of the treatment; Abacavir is a nucleoside reverse transcriptase inhibitor (NRTI) that blocks the reverse transcriptase enzyme, Lamivudine also acts as an NRTI, and Zidovudine, another NRTI, further enhances the drug’s efficacy. Trizivir is typically prescribed as part of a comprehensive HIV treatment regimen and is available in a convenient tablet form, making it easier for patients to adhere to their medication schedule. The combination of these three agents not only helps in reducing the viral load but also aids in preventing the progression of HIV to AIDS, thus significantly improving the quality of life for those affected by the virus.